rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Katherine Rielly-Gauvin

Director

Company insider

Files Form 4 as: Director, Liquidia; Director, Liquidia Technologies.

Every Form 4 they filed

In numbers

Trades disclosed
30
Buys
0
Sells
2
Bought
$0
Sold
$8.2M
Companies
2
Companies where not an officer
2
First trade
30 Oct 2019
Last trade
20 Aug 2026
Last filed
21 Aug 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
LQDA LiquidiaDirector · Biotechnology · last 20 Aug 20260 buys · 2 sells
Liquidia TechnologiesDirector · last 22 Jun 20200 buys · 0 sells

Activity over time

1 Aug – 1 Oct
201 Aug1 Sep1 Oct

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
20 Aug 2026filed 21 Aug 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—6,666 at $0.00filing
20 Aug 2026filed 21 Aug 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—11,727 at $0.00filing
20 Aug 2026filed 21 Aug 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—6,666 at $0.00filing
20 Aug 2026filed 21 Aug 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M$29K11,727 at $2.51filing
20 Aug 2026filed 21 Aug 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M$17K6,666 at $2.59filing
20 Aug 2026filed 21 Aug 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$1.3M18,393 at $72.23filing
20 Aug 2026filed 21 Aug 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—11,727 at $0.00filing
20 Aug 2026filed 21 Aug 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M$29K11,727 at $2.51filing
20 Aug 2026filed 21 Aug 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M$17K6,666 at $2.59filing
20 Aug 2026filed 21 Aug 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$1.3M18,393 at $72.23filing
19 Aug 2026filed 21 Aug 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M$59K23,455 at $2.51filing
19 Aug 2026filed 21 Aug 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M$35K13,334 at $2.59filing
19 Aug 2026filed 21 Aug 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$2.8M36,789 at $74.99filing
19 Aug 2026filed 21 Aug 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—23,455 at $0.00filing
19 Aug 2026filed 21 Aug 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—13,334 at $0.00filing
19 Aug 2026filed 21 Aug 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—23,455 at $0.00filing
19 Aug 2026filed 21 Aug 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—13,334 at $0.00filing
19 Aug 2026filed 21 Aug 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M$59K23,455 at $2.51filing
19 Aug 2026filed 21 Aug 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M$35K13,334 at $2.59filing
19 Aug 2026filed 21 Aug 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$2.8M36,789 at $74.99filing

Sectors

Health Care2

Buys in green, sells in red, by the company’s sector.

Related people

Roger JeffsChief Executive Officer · Chief Executive Officer at Liquidia, filing Form 4 there in the last year
Michael KasetaCFO and COO · CFO and COO at Liquidia, filing Form 4 there in the last year
Jason AdairChief Business Officer · Chief Business Officer at Liquidia, filing Form 4 there in the last year
Scott MoomawChief Commercial Officer · Chief Commercial Officer at Liquidia, filing Form 4 there in the last year
Russell SchundlerGeneral Counsel · General Counsel at Liquidia, filing Form 4 there in the last year
Dana BoyleChief Accounting Officer · Also traded LQDA in the last 90 days
Rajeev SaggarChief Medical Officer · Also traded LQDA in the last 90 days
Sanjeev KhindriChief Development Officer · Also traded LQDA in the last 90 days